How the strategic information improves the access to the drugs
Salvador National Institutes of Healt : National Library of Medicine 2005Tipo de conteúdo:- text
- unmediated
- volume
This work proposes the creation of a multi-field network including Health, Pharmaceuticals, Patent specialists, Information sciences professionals, and political leaders to help the Brazilian Health Ministry (MH) maintain its policy of free distribution of drugs to the AIDS patients. In fact, the result of the Industrial Property of pharmaceutical groups is a relevant increase in drug costs which becomes too significant for Brazil, as for other Emergent and Developing Countries. The strategic analysis of the drug information, recommended against AIDS, collected in specialized and Internet databases, will be used to create a true Strategic Information system so as to: identify drugs described in patents that are of public domain; identify substitution drugs which could be bought or manufactured at a lower cost; define restriction rules concerning the use of the drugs; identify purchasing possibilities of licenses to manufacture drugs in Brazil; investigate the strategy of obtaining the drug in question to negotiate with the laboratory assignee a price reduction using the following arguments: a) the threat of nullity of the patent following the identification of faults in the patent filling process; b) the obligatory threat of the patent having as base the proof that the government is able to manufactured the drug at a lower cost; obtain the patent nullity, which was patented without conformity to one of the articles in the LPI 9.279/96. The system which will be developed in Brazil will have to be reproducible, so that it can be easily transposable in other countries also concerned with the problems involved in Industrial Property and the high cost of drugs recommended in the combat of AIDS. On the other hand, this system could also be used in the prevention or combat of other illnesses
Não há comentários sobre este título.